亚洲图片国产日韩欧美_国产区精品欧美日韩在线蜜臀_韩国日本三级在线观看手机视频_影音先锋国产精品无码_亚洲日本va一区二区三区_亚洲精品无码丰满少妇av_天堂在线中文www_扒开粉嫩的小缝开始亲吻男女_尤蜜在线观看免费观看_久久毛片欧洲无码视频

×

本司產(chǎn)品僅用于科研,不用于臨床診斷和治療

全國免費熱線:400-999-2100

您身邊的細胞培養(yǎng)專家!

所有分類
  • 所有分類
  • 細胞系
  • 原代細胞
  • 血清
  • 細胞培養(yǎng)基
  • 輔助試劑
  • 細胞凋亡檢測試劑盒
  • 細胞房除菌產(chǎn)品
熱搜: 胎牛血清 VERO RAW264.7 成纖維細胞 間充質(zhì)干細胞 上皮細胞

忘記密碼

個人郵箱:
驗證碼: captcha

賬號激活

個人郵箱:
×
當前位置:首頁 >> 產(chǎn)品中心 >> 細胞資源庫 >> 細胞系 >> 小鼠

產(chǎn)品中心Cell Resources

聯(lián)系我們CONTACT US

  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)

H22 (小鼠肝癌細胞) (STR鑒定正確)

貨號:CL-0341

規(guī)格:1×10?cells/T25培養(yǎng)瓶

價格: ¥1600

生長培養(yǎng)基:RPMI-164010% FBS1% P/S

數(shù)量: - +

  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)
  • H22 (小鼠肝癌細胞) (STR鑒定正確)

推薦搭配

套餐1:

H22 (小鼠肝癌細胞) (STR鑒定正確) ¥1600
H22細胞專用培養(yǎng)基
  • ¥350
  • ¥450

現(xiàn)單獨購買該產(chǎn)品也可享受限時優(yōu)惠價!

細胞培養(yǎng)最優(yōu)解!

套餐組合價:¥1950¥2050

加入購物車

搭配套餐已成功加入購物車!

產(chǎn)品概述
產(chǎn)品信息
名稱 H22 (小鼠肝癌細胞) (STR鑒定正確)
別稱 Hepatoma-22; Hepatoma 22
種屬 小鼠
生長特性 懸浮細胞
細胞形態(tài) 淋巴母細胞樣
凍存條件 凍存液:55% 基礎培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮
培養(yǎng)方案A(默認)
生長培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
推薦傳代比例 3×10^5-5×10^5cells/mL
推薦換液頻率 2-3次/周
注意事項 H22細胞是小鼠腹水瘤細胞,體外培養(yǎng)傳代4-5代左右,細胞活力會將低,狀態(tài)會變差,可通過腹水培養(yǎng)恢復細胞活力。該細胞為懸浮細胞,請注意離心收集細胞懸液;請勿直接倒掉細胞培養(yǎng)液。
參考資料(來源文獻)
背景描述 H22細胞是分離自小鼠腹水,由大連醫(yī)科學院建立。
年齡(性別) 不詳
組織來源 肝;肝癌
細胞類型 腫瘤細胞
腫瘤類型 肝膽癌細胞
STR鑒定
  • STR位點信息
    18-3 11,17
    6-7 13
    5-5 14
    X-1 25
    1-2 18,19
    7-1 24.2
    8-1 17,18
    1-1 15,16
    19-2 13
    15-3 19.3,20.3,25.3
    12-1 17
    6-4 15.3,16.3
    4-2 19.3,20.3
    3-2 13,14
    2-1 9
    13-1

    16.2

    11-2 16
    17-2 13,15
  • STR鑒定圖
參考文獻
文獻列表
  • Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells(2019/10/31)

    作者:Junyu Xiang, Ni Zhang, Juan Feng

    期刊:Gastroenterology

    DOI:10.1053/j.gastro.2019.10.025

    影響因子 :29.400

    引用產(chǎn)品:CL-0105 CL-0341

  • Targeting RORγ inhibits the growth and metastasis of hepatocellular carcinoma(2024/02/02)

    作者:Qianqian Liu, Junhua Wang, Huizi Sun

    期刊:MOLECULAR THERAPY

    DOI:10.1016/j.ymthe.2024.01.032

    影響因子 :12.400

    引用產(chǎn)品:CL-0341

  • Suppression of hepatocellular carcinoma by Ulva lactuca ulvan via gut microbiota and metabolite interactions(2023/04/17)

    作者:Yinghui Qiu, Jingxiang Xu, Wei Liao

    期刊:Journal of Advanced Research

    DOI:10.1016/j.jare.2023.04.008

    影響因子 :10.700

    引用產(chǎn)品:CL-0341

  • Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer(2022/12/10)

    作者:Xiaoyan Yang, Jinguo Zhang, Qiaomei Zhou

    期刊:JOURNAL OF NANOBIOTECHNOLOGY

    DOI:10.1186/s12951-022-01738-6

    影響因子 :10.200

    引用產(chǎn)品:CL-0007 CL-0029 CL-0042 CL-0233 CL-0341

  • ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression(2022/08/01)

    作者:Yu You, Diguang Wen, Lu Zeng

    期刊:International Journal of Biological Sciences

    DOI:10.7150/ijbs.70149

    影響因子 :9.200

    引用產(chǎn)品:CL-0102 CL-0103 CL-0120 CL-0212 CL-0233 CL-0341

  • Nanoparticles prepared by polysaccharides extracted from Biyang floral mushroom loaded with resveratrol: Characterization, bioactivity and release behavior under in vitro digestion(2023/06/12)

    作者:Keke Liu, Yongqi Liu, Jike Lu

    期刊:FOOD CHEMISTRY

    DOI:10.1016/j.foodchem.2023.136612

    影響因子 :8.800

    引用產(chǎn)品:CL-0341

  • The combination of Brassica rapa L. polysaccharides and cisplatin enhances the anti liver cancer effect and improves intestinal microbiota and metabolic disorders(2024/03/07)

    作者:Hanrui Kong, Jun Yang, Xiaojing Wang

    期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

    DOI:10.1016/j.ijbiomac.2024.130706

    影響因子 :8.200

    引用產(chǎn)品:CL-0341

  • Improved anti-hepatocellular carcinoma effect by enhanced Co-delivery of Tim-3 siRNA and sorafenib via multiple pH triggered drug-eluting nanoparticles(2022/07/06)

    作者:Chenghua Song, Jia Zhang, Ruichao Wen

    期刊:Materials Today Bio

    DOI:10.1016/j.mtbio.2022.100350

    影響因子 :8.200

    引用產(chǎn)品:CL-0105 CL-0341

  • Fluorinated carboxymethyl chitosan-based nano-prodrugs for precisely synergistic chemotherapy(2022/12/20)

    作者:Chensong Zhang, Yining Song, Guoqing Yan

    期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

    DOI:10.1016/j.ijbiomac.2022.12.157

    影響因子 :8.200

    引用產(chǎn)品:CL-0016 CL-0103 CL-0149 CL-0341

  • Huaier improves the efficacy of anti-PD-L1 Ab in the treatment of hepatocellular carcinoma by regulating tumor immune microenvironment(2023/11/04)

    作者:Huawei Li, Jia You, Yuanfeng Wei

    期刊:PHYTOMEDICINE

    DOI:10.1016/j.phymed.2023.155189

    影響因子 :7.900

    引用產(chǎn)品:CL-0341

  • Assisting anti-PD-1 antibody treatment with a liposomal system capable of recruiting immune cells(2019/04/23)

    作者:Boyang Zhou, Qiongchao Jiang, Xiaoyun Xiao

    期刊:Nanoscale

    DOI:10.1039/C9NR01434A

    影響因子 :6.700

    引用產(chǎn)品:CL-0341

  • Lactose-modified enzyme-sensitive branched polymers as a nanoscale liver cancer-targeting MRI contrast agent(2022/12/12)

    作者:Xiaoqin Zhang, Xiaoming Wang, Zhiqian Li

    期刊:Nanoscale

    DOI:10.1039/D2NR04020D

    影響因子 :6.700

    引用產(chǎn)品:CL-0341

  • Astaxanthin slows down skeletal muscle atrophy in H22 tumor-bearing mice during sorafenib treatment by modulating the gut microbiota(2023/12/20)

    作者:Pengfei Ren, Han Yue, Qingjuan Tang

    期刊:Food & Function

    DOI:10.1039/D3FO04633H

    影響因子 :6.100

    引用產(chǎn)品:CL-0341

  • Protective effects of low-temperature plasma on cisplatin-induced nephrotoxicity(2021/12/14)

    作者:Peng Guo,?Nan Zhang,?Juan Li?

    期刊:Life Sciences

    DOI:10.1016/j.lfs.2021.120230

    影響因子 :6.100

    引用產(chǎn)品:CL-0341

  • Glycyrrhizic Acid-Based Liposome for Tumor-Targeted Delivery of Cantharidin(2024/01/02)

    作者:Yuxiang Wang, Wenzhen Wang, Hailu Yao

    期刊:ACS Applied Nano Materials

    DOI:10.1021/acsanm.3c05019

    影響因子 :5.900

    引用產(chǎn)品:CL-0341

  • Antitumor Activity of Carboxymethyl Pachymaran with Different Molecular Weights Based on Immunomodulatory and Gut Microbiota(2023/10/25)

    作者:Yalin Zhao, Xi Feng, Lijia Zhang

    期刊:Nutrients

    DOI:10.3390/nu15214527

    影響因子 :5.900

    引用產(chǎn)品:CL-0341

  • Ultrasound Molecular Imaging as a Potential Non-invasive Diagnosis to Detect the Margin of Hepatocarcinoma via CSF-1R Targeting(2020/07/14)

    作者:Qiongchao Jiang, Yunting Zeng

    期刊:FRONT BIOENG BIOTECH

    DOI:10.3389/fbioe.2020.00783

    影響因子 :5.700

    引用產(chǎn)品:CL-0341

  • Ultrasound Molecular Imaging as a Potential Non-invasive Diagnosis to Detect the Margin of Hepatocarcinoma via CSF-1R Targeting(2020/7/14)

    作者:Jiang Qiongchao, Zeng Yunting, Xu Yanni

    期刊:Frontiers in Bioengineering and Biotechnology

    DOI:10.3389/fbioe.2020.00783

    影響因子 :5.700

    引用產(chǎn)品:CL-0341

  • Engineering M1-derived nanovesicles loading with docosahexaenoic acid synergizes ferroptosis and immune activation for treating hepatocellular carcinoma(2023/03/07)

    作者:Ming Meng, Xia Zhang, Qian Li

    期刊:Cancer Nanotechnology

    DOI:10.1186/s12645-023-00166-x

    影響因子 :5.700

    引用產(chǎn)品:CL-0341

  • Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma(2024/02/13)

    作者:Meiying Song, Luoyang Wang, Suli Jiang

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2024.111601

    影響因子 :5.600

    引用產(chǎn)品:CL-0341

  • Dietary supplementation of α-linolenic acid-rich flaxseed oil enhances anti-PD-1 protection against orthotopic hepatocellular carcinoma by reshaping gut homeostasis and improving anti-tumor immunity via gut-liver axis in mice(2024/04/01)

    作者:Jian Liu, Yiwei Li, Wenke Shen

    期刊:Journal of Functional Foods

    DOI:10.1016/j.jff.2024.106157

    影響因子 :5.600

    引用產(chǎn)品:CL-0341

  • Astaxanthin exerts an adjunctive anti-cancer effect through the modulation of gut microbiota and mucosal immunity(2024/01/28)

    作者:Pengfei Ren, Han Yue, Qingjuan Tang

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2024.111553

    影響因子 :5.600

    引用產(chǎn)品:CL-0341

  • Anti-tumor effect of Inonotus hispidus petroleum ether extract in H22 tumor-bearing mice and analysis its mechanism by untargeted metabonomic(2021/12/11)

    作者:ZhijunLia,HaiyingBao

    期刊:Journal Of Ethnopharmacology

    DOI:10.1016/j.jep.2021.114898

    影響因子 :5.400

    引用產(chǎn)品:CL-0341

  • Aidi injection enhances the anti-tumor impact of doxorubicin in H22 tumor-containing mice(2022/12/05)

    作者:Yuan Lu, Shuai Zhang, Xiaoqin Zhu

    期刊:JOURNAL OF ETHNOPHARMACOLOGY

    DOI:10.1016/j.jep.2022.115968

    影響因子 :5.400

    引用產(chǎn)品:CL-0341

  • Enhancing anti-tumor therapy with agmatine-cholesterol conjugate liposomes: in vitro and in vivo evidence(2023/09/27)

    作者:Yanzhi Wang, Linchao Wang, Hanyue Chang

    期刊:Drug Delivery and Translational Research

    DOI:10.1007/s13346-023-01433-5

    影響因子 :5.400

    引用產(chǎn)品:CL-0341

  • Astaxanthin Augmented the Anti-Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibition of the JAK2/STAT3 Signaling Pathway and Mitigation of Hypoxia within the Tumor Microenvironment(2023/12/07)

    作者:Pengfei Ren, Qingjuan Tang, Xinjia He

    期刊:MOLECULAR NUTRITION & FOOD RESEARCH

    DOI:10.1002/mnfr.202300569

    影響因子 :5.200

    引用產(chǎn)品:CL-0341

  • Comparative study on the anti-tumor effect of steroids derived from different organisms in H22 tumor-bearing mice and analysis of their mechanisms(2023/12/13)

    作者:Huimin Huo, Haiying Bao

    期刊:EUROPEAN JOURNAL OF PHARMACOLOGY

    DOI:10.1016/j.ejphar.2023.176269

    影響因子 :5.000

    引用產(chǎn)品:CL-0341

  • KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D(2021/07/02)

    作者:Yonglan Wang, Kun Cao

    期刊:Journal of Immunology Research

    DOI:10.1155/2021/9965099

    影響因子 :4.493

    引用產(chǎn)品:CL-0341

  • CDK1-SRC Interaction-Dependent Transcriptional Activation of HSP90AB1 Promotes Antitumor Immunity in Hepatocellular Carcinoma(2023/11/10)

    作者:Yijie Zhang, Dehui Yi

    期刊:JOURNAL OF PROTEOME RESEARCH

    DOI:10.1021/acs.jproteome.3c00379

    影響因子 :4.400

    引用產(chǎn)品:CL-0341

  • EGCG enhances cancer cells sensitivity under 60Coγ radiation based on miR-34a/Sirt1/p53(2019/09/05)

    作者:Qiaozhen Kang, Xiaomiao Zhang, Nana Cao

    期刊:Food And Chemical Toxicology

    DOI:10.1016/j.fct.2019.110807

    影響因子 :4.300

    引用產(chǎn)品:CL-0341

  • Green Synthesis of Gold Nanoparticles from Polygahatous Polysaccharides and Their Anticancer Effect on Hepatic Carcinoma through Immunoregulation(2024/05/02)

    作者:Maodong Leng, Huiqin Jiang, Sitong Zhang

    期刊:ACS Omega

    DOI:10.1021/acsomega.4c01025

    影響因子 :4.100

    引用產(chǎn)品:CL-0341

  • Paeoniflorin increases the anti-tumor efficacy of sorafenib in tumor-bearing mice with liver cancer via suppressing the NF-κb/PD-l1 axis(2024/01/13)

    作者:Junfei Li, Chenghui Zhu, Zengyu Zhang

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2024.e24461

    影響因子 :4.000

    引用產(chǎn)品:CL-0341

  • Ajmalicine induces the pyroptosis of hepatoma cells to exert the antitumor effect(2023/12/08)

    作者:Zhangchi Sun, Chenfang Ma, Xiaolan Zhan

    期刊:JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

    DOI:10.1002/jbt.23614

    影響因子 :3.600

    引用產(chǎn)品:CL-0341

  • Quercetin, the Ingredient of Xihuang Pills, Inhibits Hepatocellular Carcinoma by Regulating Autophagy and Macrophage Polarization(2022/12/20)

    作者:Ruoxia Wu, Ting Zhou, Jiaqing Xiong

    期刊:Frontiers in Bioscience-Landmark

    DOI:10.31083/j.fbl2712323

    影響因子 :3.100

    引用產(chǎn)品:CL-0103 CL-0341

  • Cistanche tubulosa Phenylethanoid Glycosides Induce Apoptosis of Hepatocellular Carcinoma Cells by Mitochondria-Dependent and MAPK Pathways and Enhance Antitumor Effect through Combination with Cisplatin:(2021/5/5)

    作者:Pengfei Yuan, Changshuang Fu, Yi Yang

    期刊:Integrative Cancer Therapies

    DOI:10.1177/15347354211013085

    影響因子 :2.900

    引用產(chǎn)品:CL-0341

  • Radiosensitization potential of caffeic acid phenethyl ester and the long non-coding RNAs in response to 60Coγ radiation in mouse hepatoma cells(2020/12/24)

    作者:Xiaomiao Zhang, Qiaozhen Kang, Zhenyu Ji

    期刊:Radiation Physics and Chemistry

    DOI:10.1016/j.radphyschem.2020.109326

    影響因子 :2.900

    引用產(chǎn)品:CL-0341

  • Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-κB-HIF-2α-SerpinB3 Pathway(2022/10/15)

    作者:Junfei Li, Xiaorong Zheng, Hongyan Zhang

    期刊:Evidence-based Complementary and Alternative Medicine

    DOI:10.1155/2022/1911311

    影響因子 :2.650

    引用產(chǎn)品:CL-0341

  • Antitumor Effects of Curcumin and Glycyrrhetinic Acid-Modified Curcumin-Loaded Cationic Liposome by Intratumoral Administration(2020/05/30)

    作者:Mingxiang Chang, Meimei Wu, Hanmin Li

    期刊:Evidence-Based Complementary and Alternative Medicine

    DOI:10.1155/2020/4504936

    影響因子 :2.650

    引用產(chǎn)品:CL-0341

  • 點擊展開收起列表
FAQs

Q:{{item.question}}

A:

暫無數(shù)據(jù)
產(chǎn)品資料
注:百度瀏覽器無法支持掃一掃功能,請輸入識別碼,獲取相應產(chǎn)品資料

識別碼示意圖

確定
邱國娜/胡文君

邱國娜/胡文君

【 上海 】

何帆

何帆

【 陜西、甘肅、寧夏、青海、新疆 】

 熊經(jīng)理

熊經(jīng)理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

劉本佳

劉本佳

【江蘇(除南京外)】

章臣雄

章臣雄

【 廣州 】

杜焱煒

杜焱煒

【 四川、云南、西藏 】

田博浩

田博浩

【 重慶、貴州 】

石文平

石文平

【 北京、遼寧 】

胡文君

胡文君

【江西】

李榮楓

李榮楓

【 天津、河北、內(nèi)蒙古、山西 】

陳雨蘭

陳雨蘭

【 山東 】

尹國文

尹國文

【浙江】

唐小花

唐小花

【 吉林、黑龍江 】

付帥

付帥

【 安徽 】

朱俊宇

朱俊宇

【 河南、廣西 】

李慶祖

李慶祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文強

梅文強

【福建】

林釗光

林釗光

【南京】

微信掃一掃咨詢

微信掃一掃咨詢

在線客服
關閉
在線咨詢
聯(lián)系銷售

關注微信公眾號